Also, the expression of RPS6KA3 (Xp22.12), which is downstream of MAPK1/ERK2 signaling and mediates inhibitory feedback, was reduced in the HCC-like component (approximately 2.6-fold; Figure 3). This evidence concerns the gene RPS6KA3 and hepatocellular carcinoma.